In addition to spatial transcriptomics, other new methods like the spQSP have also shown that CD8+ T cells and macrophages are more closely distributed in HCC patients resistant to a combination of targeted treatment and immunotherapy 19. This evidence concerns the gene CD8A and hepatocellular carcinoma.